Clincosm LogoSign in Get a demo

neoplasms, nerve tissue

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Glioma, Recurrence, Disease Attributes Trial (Vorasidenib)

Available
  • Glioma
  • +10 more
  • (no location specified)
Oct 19, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

Recruiting
  • Lung Neoplasm Malignant
  • +18 more
  • Fairfax, Virginia
    New Experimental Therapeutics of Virginia (NEXT Oncology)
Mar 29, 2022

Pralsetinib to Best Available Therapy in RET-Fusion Positive

Enrolling by invitation
  • RET-fusion Non Small Cell Lung Cancer
  • +16 more
    • New York, New York
    • +2 more
    Aug 9, 2021

    Glioblastoma Multiforme, Glioblastoma, Glioma Trial in Taoyuan City (NaviFUS System, Bevacizumab)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Taoyuan City, Taiwan
      Linkou Chang Gung Memorial Hospital
    Aug 2, 2021

    Spanish Series of Patients Treated With Radionuclide Lutetium177

    Recruiting
    • Neuroendocrine Tumors
    • +17 more
    • Lutetium [177Lu] oxodotreotide/dotatate
    • Santiago De Compostela, A Coruña, Spain
    • +18 more
    Jul 1, 2021

    Glioblastoma, Glioma, Tumors, Neuroepithelial Trial in Hangzhou (Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12,

    Recruiting
    • Glioblastoma
    • +7 more
    • Dendritic Cell/Tumor Fusion Vaccine
    • +2 more
    • Hangzhou, Zhejiang, China
    • +1 more
    Jun 7, 2020

    Glioblastoma Multiforme, Brain Tumor, Glioblastoma Trial in Taoyuan City (NaviFUS System)

    Completed
    • Glioblastoma Multiforme
    • +5 more
    • NaviFUS System
    • Taoyuan City, Taiwan
      Linkou Chang Gung Memorial Hospital
    Jun 20, 2019

    Tumors, Nerve Tissue, Neurofibromatosis 1, Heredodegenerative Disorders, Nervous System Trial (Selumetinib (AZD6244 hyd sulfate)

    Withdrawn
    • Neoplasms, Nerve Tissue
    • +3 more
    • Selumetinib (AZD6244 hyd sulfate) 50mg/dose
    • Selumetinib (AZD6244 hyd sulfate) 25mg/m2
    • (no location specified)
    Apr 3, 2019

    Neuroblastoma, Tumors, Nerve Tissue Trial (Autologous Hematopoietic Progenitor Cell Transplant, KLH and Tumor Lysate Pulsed DC

    Withdrawn
    • Neuroblastoma
    • Neoplasms, Nerve Tissue
    • Autologous Hematopoietic Progenitor Cell Transplant
    • KLH and Tumor Lysate Pulsed DC Vaccine
    • (no location specified)
    Aug 29, 2017

    Combined O-(2-[18F]Fluoroethyl)-L-tyrosine Positron Emission

    Unknown status
    • Glioblastoma
    • +8 more
      • Munich, Bavaria, Germany
        University of Munich, Dep. of Radiation Oncology
      Dec 17, 2012